This classification might be used in the future, if validated, to predict outcomes of resected UTUC patients and help stratify those that may benefit from preoperative chemotherapy or adjuvant FGFR3-targeted agents [17]. Here, FGFR3 is linked to renal pelvis/ureter urothelial carcinoma.